Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
In the latest session, Aldeyra Therapeutics Inc (NASDAQ: ALDX) closed at $5.25 down -0.19% from its previous closing price of $5.26. In other words, the price has decreased by -$0.19 from its previous closing price. On the day, 1.03 million shares were traded. ALDX stock price reached its highest trading level at $5.37 during the session, while it also had its lowest trading level at $5.04.
Ratios:
For a deeper understanding of Aldeyra Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.82 and its Current Ratio is at 2.82. In the meantime, Its Debt-to-Equity ratio is 0.28 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 03 ’25 when PERCEPTIVE ADVISORS LLC sold 3,400,000 shares for $1.42 per share. The transaction valued at 4,828,000 led to the insider holds 5,875,851 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALDX now has a Market Capitalization of 315238880 and an Enterprise Value of 248088096.
Stock Price History:
The Beta on a monthly basis for ALDX is 0.78, which has changed by 0.11464965 over the last 52 weeks, in comparison to a change of 0.17279088 over the same period for the S&P500. Over the past 52 weeks, ALDX has reached a high of $7.20, while it has fallen to a 52-week low of $1.14. The 50-Day Moving Average of the stock is 27.60%, while the 200-Day Moving Average is calculated to be 15.86%.
Shares Statistics:
For the past three months, ALDX has traded an average of 1.04M shares per day and 1046310 over the past ten days. A total of 60.05M shares are outstanding, with a floating share count of 58.15M. Insiders hold about 2.92% of the company’s shares, while institutions hold 57.22% stake in the company. Shares short for ALDX as of 1753920000 were 5034432 with a Short Ratio of 4.44, compared to 1751241600 on 4465802. Therefore, it implies a Short% of Shares Outstanding of 5034432 and a Short% of Float of 8.66.
Earnings Estimates
The dynamic stock of Aldeyra Therapeutics Inc (ALDX) is currently attracting attention from 2.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is -$0.17, with high estimates of -$0.16 and low estimates of -$0.17.
Analysts are recommending an EPS of between -$0.62 and -$0.65 for the fiscal current year, implying an average EPS of -$0.63. EPS for the following year is $0.56, with 4.0 analysts recommending between $1.67 and -$0.44.
Revenue Estimates
Based on 6 analysts’ estimates, the company’s revenue will be $77.12M in the next fiscal year. The high estimate is $168M and the low estimate is $16M.
